Maze Therapeutics Inc (MAZE)

EBITDA Margin

-649.44%

TTM · Period ending:

MAZE logo

MAZE EBITDA Margin

Latest reported-649.44%
MAZE TTM EBITDA Margin (36.82% → -649.44%)
High-resolution chart · PNG

MAZE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Maze Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-649.44%
-597.565%
-4,740.96%
33.5176%
33.8507%
35.969%
36.817%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.